BNGO
Price:
$0.2024
Market Cap:
$20.64M
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight. The company also provides Saphyr and Bionano compute servers; and NxClinical which offers one system for analysis and interpretation of genomic variants from microarray and next-g...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2018-08-21
Stock Exchange
NASDAQ
Ticker
BNGO
According to Bionano Genomics, Inc.’s latest financial reports and current stock price. The company's current ROE is -176.27%. This represents a change of 262.79% compared to the average of -48.59% of the last 4 quarters.
The mean historical ROE of Bionano Genomics, Inc. over the last ten years is -165.76%. The current -176.27% ROE has changed 6.33% with respect to the historical average. Over the past ten years (40 quarters), BNGO's ROE was at its highest in in the June 2019 quarter at 569.94%. The ROE was at its lowest in in the December 2019 quarter at -218.63%.
Average
-165.76%
Median
-85.21%
Minimum
-825.63%
Maximum
69.15%
Discovering the peaks and valleys of Bionano Genomics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 354.77%
Maximum Annual ROE = 69.15%
Minimum Annual Increase = -492.22%
Minimum Annual ROE = -825.63%
Year | ROE | Change |
---|---|---|
2023 | -241.78% | 354.77% |
2022 | -53.17% | 147.44% |
2021 | -21.49% | -81.68% |
2020 | -117.25% | -85.80% |
2019 | -825.63% | 352.51% |
2018 | -182.46% | -492.22% |
2017 | 46.52% | -32.72% |
The current ROE of Bionano Genomics, Inc. (BNGO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-105.48%
5-year avg
-251.87%
10-year avg
-165.76%
Bionano Genomics, Inc.’s ROE is less than Intuitive Surgical, Inc. (15.59%), greater than Innovative Eyewear, Inc. (-24906.65%), greater than Stereotaxis, Inc. (-115.14%), greater than NEXGEL, Inc. (-76.97%), greater than Microbot Medical Inc. (-218.30%), less than STAAR Surgical Company (5.39%), greater than Envista Holdings Corp (-37.24%), less than G Medical Innovations Holdings Ltd (208.58%), less than Becton, Dickinson and Company (5.15%), less than West Pharmaceutical Services, Inc. (18.35%), less than ResMed Inc. (23.22%), less than Wearable Health Solutions, Inc. (12.86%), less than BioLife Sciences Inc. (0%), less than Psykey, Inc. (671.52%), greater than Predictive Oncology Inc. (-303.92%), greater than Sharps Technology, Inc. (-110.41%), less than GlucoTrack, Inc. (1.63%), less than Meihua International Medical Technologies Co., Ltd. (6.27%),
Company | ROE | Market cap |
---|---|---|
15.59% | $191.28B | |
-24906.65% | $13.97M | |
-115.14% | $197.42M | |
-76.97% | $32.19M | |
-218.30% | $16.88M | |
5.39% | $1.23B | |
-37.24% | $3.26B | |
208.58% | $1.80M | |
5.15% | $65.82B | |
18.35% | $24.00B | |
23.22% | $34.03B | |
12.86% | $182.67K | |
0% | $156.68K | |
671.52% | $392.47K | |
-303.92% | $4.97M | |
-110.41% | $3.61M | |
1.63% | $4.14M | |
6.27% | $9.08M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bionano Genomics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Bionano Genomics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Bionano Genomics, Inc.'s ROE?
How is the ROE calculated for Bionano Genomics, Inc. (BNGO)?
What is the highest ROE for Bionano Genomics, Inc. (BNGO)?
What is the 3-year average ROE for Bionano Genomics, Inc. (BNGO)?
What is the 5-year average ROE for Bionano Genomics, Inc. (BNGO)?
How does the current ROE for Bionano Genomics, Inc. (BNGO) compare to its historical average?